Retinal dysfunction in Alzheimer's disease mouse models
阿尔茨海默病小鼠模型的视网膜功能障碍
基本信息
- 批准号:10289116
- 负责人:
- 金额:$ 39.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-30 至 2023-06-30
- 项目状态:已结题
- 来源:
- 关键词:AffectAllelesAlzheimer&aposs DiseaseAlzheimer&aposs disease diagnosisAlzheimer&aposs disease modelAlzheimer&aposs disease patientAlzheimer&aposs disease riskAlzheimer’s disease biomarkerAmericanAnatomyAnimal ModelAnimalsApolipoprotein EArchitectureAreaAstrocytesBiological AssayBiological MarkersBlindnessBlood GlucoseBlood VesselsBlood flowBrainClinicalCollaborationsColor VisionsCommunicationComplications of Diabetes MellitusDataDefectDementiaDepth PerceptionDevelopmentDiabetes MellitusDiabetic RetinopathyDiagnosisDiseaseEarly DiagnosisElderlyElectrophysiology (science)ElectroretinographyEnsureEnvironmentEquilibriumEvaluationExhibitsEyeFluorescein AngiographyFoundationsFunctional disorderFutureGenesGeneticGenotypeGlaucomaGoalsGrantHigh Fat DietHistologyHyperglycemiaImpaired cognitionImpairmentInstitutionInsulin ReceptorKnock-in MouseKnowledgeLate Onset Alzheimer DiseaseLightLinkLongitudinal StudiesMemoryMicrogliaMicrovascular DysfunctionMissionModelingMolecularMuller&aposs cellMusNational Eye InstituteNational Institute on AgingNerve DegenerationNeuraxisNeurodegenerative DisordersNeurogliaOptic DiskOptical Coherence TomographyPathogenesisPathologicPathologyPatternPhenotypePlayPositioning AttributePotassiumPublic HealthReceptor SignalingRegulationResearchResearch DesignResearch SupportResourcesRetinaRetinal DiseasesRetinal Ganglion CellsRiskRisk FactorsRoleSeriesSignal TransductionSolidStructureSynapsesTestingThickThinkingThinnessVisionVision DisordersWaterWorkabeta depositionage relatedapolipoprotein E-4basebiomarker developmentbrain tissuecerebrovascular imagingcognitive functiondensitydiabeticdrug developmentganglion cellgenetic risk factorhuman old age (65+)macrogliamacular edemamouse modelneuroimagingneurotransmissionnext generationnovelobject recognitionrelating to nervous systemresponseretinal angiogenesisretinal axonsensorsuccesstranscriptometranscriptome sequencingtranscriptomicstreatment responsevisual dysfunctionwater channel
项目摘要
Project Summary
Alzheimer’s disease (AD) is the most common dementia resulting in progressive impairment in memory and
thinking and affecting millions of older adults worldwide, with no cure. The eye, as part of the central nervous
system, exhibits a range of defects in AD, such as retinal thinning, ganglion cell loss, microvascular deficit and
Müller cell dysfunction. The eye provides a transparent window for studying neural and vascular defects, thus
can aid in biomarker development in AD. This grant supplement will capitalize on this unique position of the eye
in studying pathological aspects of AD with the potential to develop biomarkers for assessment of AD. It builds
on the solid foundation of the current R01EY027779, including ocular phenotyping and functional assessment of
Kif4.1 channels in Müller cells, but extends the work from diabetic retinopathy into AD.
Late-onset AD (LOAD) is the most common form of AD, and genetics plays a critical role in AD pathogenesis,
with apolipoprotein e4 (APOE4) as a leading factor. Model Organism Development & Evaluation of Late-Onset
Alzheimer’s disease (MODEL-AD) is a consortium that is developing the next generation of mouse models
relevant to LOAD and characterizing various phenotypes in these models. We will leverage this unique MODEL-
AD resource to study the ocular phenotype in APOE4KI mice (LOAD-risk) in comparison to APOE3KI (LOAD-
neutral). Our pragmatic study design will first characterize these mice in a series of visual function assays,
explore their retinal transcriptome for markers of neurodegeneration and compare with that of brain tissue, and
study Kir4.1 channels in Müller cells, where APOE4 is mainly concentrated. In a second set of studies, we will
challenge these mice to high-fat diet treatment to study retinal function in the hyperglycemic milieu and test
whether the presence of APOE4 genotype precipitates a diabetic retinopathy (DR) phenotype, the most common
complication of diabetes. The above study design is based on our preliminary data which demonstrate a vascular
deficit in the brain and increased blood glucose in response to a high-fat diet in APOE4 animal models. To ensure
the success of the project, we have gathered a team of experts in both eye and AD research.
The research in this supplement will advance the AD research field in a variety of ways: (i) study of retinal
vasculature may aid in the early diagnosis of AD; (ii) transcriptomics will identify novel targets altered in AD
retinas, which will help in understanding the disease pathogenesis and future drug development; (iii) brain Kir4.1
channels are downregulated in AD; however, how APOE4 affects their function is not known. Our studies will
point towards studying mechanisms in this direction; (iv) DR is a blinding eye condition, and AD patients
demonstrate a correlation with DR. Our studies will shed light on the link between these two pathologies; (v) our
studies will contribute to MODEL-AD’s goal of characterizing the phenotype of AD models and establish a
paradigm for ocular assessments of future models.
项目摘要
阿尔茨海默氏病(AD)是最常见的痴呆,导致记忆的进行性损害,
思考并影响着全世界数百万老年人,无法治愈。眼睛作为中枢神经的一部分
系统,表现出AD的一系列缺陷,如视网膜变薄,神经节细胞损失,微血管缺陷和
米勒细胞功能障碍。眼睛为研究神经和血管缺陷提供了透明的窗口,
可以帮助AD生物标志物的开发。这项补助金补充将利用眼睛的这一独特位置
在研究AD的病理学方面具有开发用于评估AD的生物标志物的潜力。它建立
在当前R 01 EY 027779的坚实基础上,包括眼部表型和功能评估,
Kif4.1通道的Müller细胞,但扩展的工作从糖尿病视网膜病变到AD。
晚发性AD(LOAD)是AD最常见的形式,遗传学在AD发病机制中起关键作用,
以载脂蛋白E4(APOE 4)为主导因子。模式生物开发和晚发型评价
阿尔茨海默病(MODEL-AD)是一个正在开发下一代小鼠模型的财团
与LOAD相关并表征这些模型中的各种表型。我们将利用这一独特的模式-
AD资源,用于研究APOE 4KI小鼠(LOAD-风险)与APOE 3 KI(LOAD-风险)的眼部表型
中性)。我们务实的研究设计将首先在一系列视觉功能测定中表征这些小鼠,
探索他们视网膜转录组的神经变性标志物,并与脑组织进行比较,
研究Müller细胞中的Kir4.1通道,其中APOE 4主要集中。在第二组研究中,我们
激发这些小鼠进行高脂饮食治疗,以研究高血糖环境中的视网膜功能,
APOE 4基因型的存在是否会导致糖尿病视网膜病变(DR)表型,最常见的
糖尿病并发症。上述研究设计是基于我们的初步数据,这些数据表明血管
在APOE 4动物模型中,高脂饮食可导致脑功能缺陷和血糖升高。确保
该项目的成功,我们已经聚集了一个专家团队在眼睛和AD研究。
本增刊中的研究将以多种方式推进AD研究领域:(i)视网膜病变的研究
血管系统可能有助于AD的早期诊断;(ii)转录组学将识别AD中改变的新靶点
视网膜,这将有助于了解疾病的发病机制和未来的药物开发;(iii)脑Kir4.1
在AD中,APOE通道下调;然而,APOE 4如何影响其功能尚不清楚。我们的研究将
指向这个方向的研究机制;(iv)DR是一种致盲性眼病,AD患者
我们的研究将揭示这两种病理之间的联系;(v)我们的研究将揭示这两种病理之间的联系。
研究将有助于MODEL AD的目标,即表征AD模型的表型,并建立一个
未来模型的视觉评估范例。
项目成果
期刊论文数量(15)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Effect of the pharmacist-managed cardiovascular risk reduction services on diabetic retinopathy outcome measures.
药剂师管理的降低心血管风险服务对糖尿病视网膜病变结果测量的影响。
- DOI:10.18549/pharmpract.2019.1.1319
- 发表时间:2019
- 期刊:
- 影响因子:0
- 作者:Weber,ZacharyA;Kaur,Palakpreet;Hundal,Amrita;Ibriga,SomnoomaH;Bhatwadekar,AshayD
- 通讯作者:Bhatwadekar,AshayD
Pharmacist-Managed Diabetic Retinopathy in Hispanic/LatinX Population.
药剂师管理的西班牙/拉丁裔人群糖尿病视网膜病变。
- DOI:10.1177/08971900221136897
- 发表时间:2024
- 期刊:
- 影响因子:1.3
- 作者:Patel,Janvi;Gonzalvo,JasmineD;Eckert,GeorgeJ;Schmelz,AndrewN;Bhatwadekar,AshayD
- 通讯作者:Bhatwadekar,AshayD
Anti-integrin therapy for retinovascular diseases.
- DOI:10.1080/13543784.2020.1795639
- 发表时间:2020-09
- 期刊:
- 影响因子:6.1
- 作者:Bhatwadekar, Ashay D.;Kansara, Viral;Luo, Qianyi;Ciulla, Thomas
- 通讯作者:Ciulla, Thomas
Circadian rhythm disruption results in visual dysfunction.
- DOI:10.1096/fba.2021-00125
- 发表时间:2022-06
- 期刊:
- 影响因子:2.7
- 作者:
- 通讯作者:
RNA therapeutics for retinal diseases.
- DOI:10.1080/14712598.2021.1856365
- 发表时间:2021-05
- 期刊:
- 影响因子:4.6
- 作者:Gemayel MC;Bhatwadekar AD;Ciulla T
- 通讯作者:Ciulla T
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ashay D Bhatwadekar其他文献
Ashay D Bhatwadekar的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ashay D Bhatwadekar', 18)}}的其他基金
miR-92a as a biomarker of diabetic retinopathy
miR-92a 作为糖尿病视网膜病变的生物标志物
- 批准号:
10677876 - 财政年份:2021
- 资助金额:
$ 39.63万 - 项目类别:
miR-92a as a biomarker of diabetic retinopathy
miR-92a 作为糖尿病视网膜病变的生物标志物
- 批准号:
10477379 - 财政年份:2021
- 资助金额:
$ 39.63万 - 项目类别:
miR-92a as a biomarker of diabetic retinopathy
miR-92a 作为糖尿病视网膜病变的生物标志物
- 批准号:
10297984 - 财政年份:2021
- 资助金额:
$ 39.63万 - 项目类别:
Short-Term Training in Ophthalmology Research for Medical Students
医学生眼科研究短期培训
- 批准号:
10615001 - 财政年份:2020
- 资助金额:
$ 39.63万 - 项目类别:
Circadian Rhythms in Müller Cell Dysfunction
Müller 细胞功能障碍的昼夜节律
- 批准号:
10186751 - 财政年份:2017
- 资助金额:
$ 39.63万 - 项目类别:
相似海外基金
Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
- 批准号:
502556 - 财政年份:2024
- 资助金额:
$ 39.63万 - 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
- 批准号:
10659303 - 财政年份:2023
- 资助金额:
$ 39.63万 - 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
- 批准号:
10674405 - 财政年份:2023
- 资助金额:
$ 39.63万 - 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
- 批准号:
10758772 - 财政年份:2023
- 资助金额:
$ 39.63万 - 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
- 批准号:
10676499 - 财政年份:2023
- 资助金额:
$ 39.63万 - 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
- 批准号:
2748611 - 财政年份:2022
- 资助金额:
$ 39.63万 - 项目类别:
Studentship
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
- 批准号:
10532032 - 财政年份:2022
- 资助金额:
$ 39.63万 - 项目类别:
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
- 批准号:
22K05630 - 财政年份:2022
- 资助金额:
$ 39.63万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
- 批准号:
10525070 - 财政年份:2022
- 资助金额:
$ 39.63万 - 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
- 批准号:
10689017 - 财政年份:2022
- 资助金额:
$ 39.63万 - 项目类别: